The right diagnosis from the right expert at the right time, anywhere in the world.
It is imperative that we seek out solutions that help address the shift in reimbursement methodologies toward improved outcomes, reduced costs, and decreased risks. Mikroscan’s technology is a great tool for pathology departments to accomplish these objectives.
Keith Kaplan, MD Pathologist
“For Research Use Only. Not for use in diagnostic procedures.”
1. U.S. Food and Drug Administration. (2020, April). Enforcement Policy for Remote Digital Pathology Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-remote-digital-pathology-devices-during-coronavirus-disease-2019-covid-19-public